Clinical Trial

Spatiotemporal Evolution of Traditional Chinese Medicine Mechanisms in Acute Ischemic Stroke Treated With Dengzhan Xixin and Dengzhan Shengmai

Study acronym: STEM-DZ
Not Yet Recruiting Phase 2/3
View on ClinicalTrials.gov →
Summary
To integrate large-scale RCT data on clinical symptoms, TCM syndromes, prognosis, and multi-omics profiles, construct a spatiotemporal dynamic network for disease-syndrome evolution of acute ischemic stroke (AIS) in the acute and recovery phases, evaluate the efficacy and safety of sequential treatment with Erigeron breviscapus-Dengzhan Shengmai for AIS, and provide evidence for precise syndrome differentiation and individualized therapy.Secondary Objective:To investigate the optimal time window and key intervention targets of sequential treatment with Erigeron breviscapus-Dengzhan Shengmai for AIS.
Trial Details
NCT Number NCT07591883
Lead Sponsor Guangdong Provincial Hospital of Traditional Chinese Medicine
Collaborators: Nanfang Hospital, Southern Medical University
Conditions Ischemic Strokes, Traditional Chinese Medicine (TCM), Prognosis
Enrollment 358 participants
Start Date 2026-06-01
Primary Completion 2029-07-30 (estimated)
Study Completion 2029-07-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-18